Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Pozycja w akcjach #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Cena akcji
$0.223
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$6.32M
Zmiana (1 dzień)
1.64%
Zmiana (1 rok)
-
Kraj
US
Handel Curanex Pharmaceuticals Inc Common Stock (CURX)

Kategoria

Historia stopy dywidendy dla Curanex Pharmaceuticals Inc Common Stock (CURX)
Stopa dywidendy (TTM) dla Curanex Pharmaceuticals Inc Common Stock (symbol akcji: CURX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Curanex Pharmaceuticals Inc Common Stock (CURX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji